The release of the snapshot containing the respective simulations can be found here: <[https://github.com/Open-Systems-Pharmacology/Verapamil-Digoxin-DDI/releases/tag/v1.1](https://github.com/Open-Systems-Pharmacology/Verapamil-Digoxin-DDI/releases/tag/v1.1)>

The verapamil-digoxin interaction was evaluated using a 11 clinical DDI studies including 12 different clinical settings ([Belz 1981](#references), [Belz 1983](#references), [Doering 1983](#references), [Johnson 1987](#references), [Klein 1982](#references), [Pedersen 1981](#references), [Pedersen 1982](#references), [Pedersen 1983](#references), [Rodin 1988](#references), [Schwartz 1982](#references), [Wiebe 2020](#references)).



| DataID | Transporter | Perpetrator / victim       | Study design                                                 | Comment                                                      | Clinical study                        |
| ------ | ------ | -------------------------- | ------------------------------------------------------------ | ------------------------------------------------------------ | ------------------------------------- |
| 16635    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID for 14 days<br />Digoxin: 0.125 mg po TID for 14 days|              | [Belz 1981](#references)          |
| 16165    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID for 14 days<br />Digoxin: 0.125 mg po TID for 14 days|              | [Belz 1983](#references)          |
| 16167    | P-gp | Verapamil / digoxin | Verapamil: 120 mg po TID for 14 days<br />Digoxin: 0.125 mg po TID for 14 days|              | [Belz 1983](#references)          |
| 16169   | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID for 14 days<br />Digoxin: 0.125 mg po TID for 14 days|              | [Doering 1983](#references)          |
| 16159    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po BID for 4 days followed by TID for 10 days<br />Digoxin: 1.0 mg iv (15 min) on day 13|              | [Johnson 1987](#references)          |
| 16174    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID for 14 days<br />Digoxin: 0.25 mg PO OD for 28 days|              | [Klein 1982](#references)          |
| 16638    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID for 10 days<br />Digoxin: 0.75 mg IV SD at day 10|              | [Pedersen 1981](#references) 
| 16163    | P-gp | Verapamil / digoxin | Verapamil: 80 mg po TID followed by 120mg TID<br />Digoxin: initial dose of 1mg PO followed by 0.0625 mg po BID followed by 0.125mg BID |              | [Pedersen 1982](#references)          |
| 16162    | P-gp | Verapamil / digoxin | Verapamil: 120 mg po TID for 12 days<br />Digoxin: 1.0 mg iv (bolus) on day 8|              | [Pedersen 1983](#references)          |
| 3063  | P-gp | Verapamil / digoxin | Verapamil: 80mg BID for 4 days followed by 80mg TID for 10 days<br />Digoxin: 0.25 mg PO BID for 14 days|              | [Rodin 1988](#references)          |
| 16175   | P-gp | Verapamil / digoxin | Verapamil: 80 mg po QID for 70 days<br />Digoxin: 0.46 mg PO OD for 85 days| Daily dose of digoxin varied between patients between 0.25 and 1 mg/day. 0.46 is the arith. mean of all dose levels.  | [Schwartz 1982](#references)          |
| 16172   | P-gp | Verapamil / digoxin | Verapamil: 120 mg po SD<br />Digoxin: 0.25 mg PO SD 1h after verapamil dosing|              | [Wiebe 2020](#references)          |






